MHC
CELG

Meyer Handelman Company’s Celgene Corp CELG Stock Holding History

Meyer Handelman Company’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-6,200
Closed -$616K – 197
2019
Q3 		$616K Hold
6,200
– – 0.03% 152
2019
Q2 		$573K Hold
6,200
– – 0.03% 162
2019
Q1 		$529K Hold
6,200
– – 0.03% 164
2018
Q4 		$397K Buy
+6,200
New +$458K 0.02% 165
2018
Q1 		– Sell
-2,100
Closed -$219K – 193
2017
Q4 		$219K Hold
2,100
– – 0.01% 189
2017
Q3 		$306K Hold
2,100
– – 0.01% 181
2017
Q2 		$273K Hold
2,100
– – 0.01% 180
2017
Q1 		$261K Hold
2,100
– – 0.01% 182
2016
Q4 		$243K Hold
2,100
– – 0.01% 181
2016
Q3 		$220K Hold
2,100
– – 0.01% 182
2016
Q2 		$207K Buy
+2,100
New +$217K 0.01% 186
2016
Q1 		– Sell
-1,800
Closed -$216K – 205
2015
Q4 		$216K Buy
+1,800
New +$208K 0.01% 198
2015
Q3 		– Sell
-1,800
Closed -$208K – 208
2015
Q2 		$208K Hold
1,800
– – 0.01% 200
2015
Q1 		$208K Hold
1,800
– – 0.01% 203
2014
Q4 		$201K Buy
+1,800
New +$190K 0.01% 194

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Meyer Handelman Company's CELG Position: Q4 2019 in Review

Meyer Handelman Company sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 6,200 shares — an estimated $616K sold.

Meyer Handelman Company first reported a position in CELG in Q4 2014 and held it in 15 quarters. The position peaked at $616K in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Meyer Handelman Company reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Meyer Handelman Company sold 6,200 Celgene Corp shares in Q4 2019, an estimated $616K.
  • Meyer Handelman Company first reported a position in Celgene Corp in Q4 2014 and held it in 15 quarters.
  • Meyer Handelman Company's Celgene Corp position peaked at $616K in Q3 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Meyer Handelman Company's 13F filing for Q4 2019, filed 23 Jan 2020.